UpHealth, Inc. UPH
0.30 +0.30
Day range unavailable
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 5.14 +1613.3% upside
Now 0.30
- Target (low)
- 3.00
- Target (mean)
- 5.14
- Target (high)
- 9.75
Ratings (-1m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 4
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.25 | -0.28 – -0.22 | -1.82 | +86.3% | 33.00M | -18.5% | 2 |
| Next quarter | -0.12 | -0.17 – -0.08 | -0.51 | +76.5% | 27.22M | -35.4% | 2 |
| Current year | -2.89 | -2.89 – -2.89 | -15.17 | +80.9% | 145.65M | -8.3% | 1 |
| Next year | -0.22 | -0.35 – -0.09 | -2.89 | +92.4% | 62.24M | -57.3% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 8, 2023 | Alliance Global Partners | Initiated | — | Buy |
| May 15, 2023 | Benchmark | Reiterated | Buy | Buy |
| Mar 2, 2023 | Northland Capital Markets | Maintained | — | Outperform |
| Jan 31, 2023 | Benchmark | Maintained | — | Buy |